Avangard CapitalMonthly report · October 2026
October 2026 Report - Avangard Systematic Fund cover
All insights

The Fund returned -3.69% in October 2026 versus +1.38% for the S&P/ASX 200 Accumulation Index

Fund return · October 2026
-3.69%
Benchmark +1.38%Difference ▼ 5.06%
Unit price
$0.9241
Net market exposure
31.7%
Strategy inception
2025-01-23
Benchmark
S&P/ASX 200 Accumulation Index
Reporting period
October 2026

Net market exposure is directional exposure to market risk: total long market value, including long ETFs, less the short exposure of inverse ETFs and less cash, measured against net asset value at month end.

Market commentary

Monthly Investment Overview

Our rules-based investment process began October almost fully invested, with cash at 5% of net asset value. The model sold into weakness through the first half of the month, lifting cash to a peak of 76% on 16 October, then redeployed from 19 October and closed the month with cash at 50.9%. Thirty-nine positions were closed, led by international and thematic funds and resources and mining, and fourteen were established across major banks, communication services, consumer, healthcare and technology, plus a United States equity hedge. The financial year to date has been a period of underperformance against the benchmark, driven by high cash in July, hedges that cost the Fund as the index recovered, and the cost of closing resources and mining positions as their trends turned.

A.L.F.R.E.D. equity market regime assessment for October 2026

Regime
Recovery
Regime assessment
A.L.F.R.E.D. read October 2026 as a recovery. Equity volatility measures trended lower across every timeframe the model tracks and broad Australian indices turned up on the short and medium-term signals, while the long-term signal remained down.

Portfolio manager's note

October was the Fund’s weakest month since the 1 July 2026 transition, and it ran against the direction of the benchmark: the index recovered while the Fund fell. Before fund fees and expenses, resources and mining cost 1.44% of the Fund, the largest drag. Materials and Gold, September’s leadership, turned down on the short, medium and long-term signals together, and A.L.F.R.E.D. closed all ten of its resources and mining positions. Communication Services cost 0.79%, almost entirely from Tuas Limited, a position established and closed between 22 and 29 October (-0.75%). Technology cost 0.47%, international and thematic funds 0.39% and industrials 0.34%. What worked was the second-half redeployment into large, liquid names: CSL Limited (+0.25%), Aristocrat Leisure (+0.19%), Pro Medicus (+0.18%) and Corporate Travel Management (+0.11%), alongside the Betashares Global Energy Companies ETF (+0.20%). Health care added 0.40% in total and the major banks 0.18%. What did not work was the first-half resources book, led by Solstice Minerals (-0.28%), DPM Metals (-0.25%), Cobre (-0.21%) and Minerals 260 (-0.21%), together with SKS Technologies (-0.23%), DXN (-0.21%) and the L1 Long Short Fund (-0.21%). The Fund’s hedges (Inverse ETF) cost 0.11% on a net basis. The domestic inverse ETF position stayed in place while Australian indices recovered (-0.20%), partly offset by a United States equity hedge reopened on 19 October (+0.15%). The call that was tested was the Fund’s defensive stance. Cash rose from 5% to 76% of the Fund between 1 and 16 October while the benchmark finished the month higher. The model sold on position-level signals rather than an index view, so the Fund held much of its capital in cash through part of the recovery. This is the cost of a process that cuts exposure when trends break, and October showed that cost plainly. Nineteen of the 25 Australian sector we model, and segment measures were up on the short-term signal at month end, 11 on the medium-term signal and 7 on the long-term signal. The long-term signal for the broad indices remained down, and 50.9% of the Fund remained in cash for that reason. Entering November, A.L.F.R.E.D.’s regime classification is Recovery. Net equity exposure stood at approximately 37 to 38% of the Fund at month end, total long positions net of the domestic and United States inverse positions, with 50.9% held in cash. Throughout October, positioning stayed within Avangard’s predefined systematic investment criteria. The exits, the cash build, the redeployment and the hedges all originated from A.L.F.R.E.D.’s model based signals, not a discretionary view on where markets were headed.

Contributors and detractors

Contributors

CSL Limited, +0.25% Betashares Global Energy Companies ETF, +0.20% Aristocrat Leisure, +0.19% Pro Medicus, +0.18% Global X Ultra Short Nasdaq hedge, +0.15%

Detractors

Tuas Limited, -0.75% Solstice Minerals, -0.28% DPM Metals, -0.25% SKS Technologies, -0.23% DXN, -0.21%

Performance summary

Strategy vs benchmark, since inception

Total returns of the Avangard Australian equity strategy against the S&P/ASX 200 Accumulation Index.

PeriodStrategyBenchmarkAlpha
1 Month-3.69%+1.38%-5.06%
3 Months-7.18%+0.45%-7.64%
6 Months-7.79%+4.60%-12.39%
1 Year-11.48%+3.69%-15.18%
FY 2025/26+15.91%+6.11%+9.80%
Since inception (cumulative)+3.22%+12.29%-9.07%
Since inception (p.a.)+1.81%+6.77%-4.97%

Track record stitches the closed Avangard Alpha Fund (23 Jan 2025 to its final pricing date, 25 Jun 2026) with the current Avangard Systematic Australian Equity Fund from 6 Jul 2026. Cumulative is the total return since 23 Jan 2025; p.a. is the annualised equivalent of that same return. All periods are point to point to the report month end, so trailing periods that exclude the 2025 drawdown can exceed the since inception figure. Returns are calculated from unit prices and are net of all fees, including management and performance fees. Past performance is not indicative of future results.

Growth of A$1,000,000 since 23 January 2025

Month-end NAV unit price series. Strategy stitches the closed Avangard Alpha Fund with the Avangard Systematic Australian Equity Fund (NAV restarts at $1.0000 from Jul 2026), plotted against the S&P/ASX 200 Accumulation Index.

Hypothetical growth of A$1,000,000 invested at strategy inception (23 Jan 2025), using month-end NAV unit prices. Past performance is not a reliable indicator of future returns.

Portfolio positioning

Exposure at month end

Invested
48.8%
Cash
51.2%
Top holding
3.1%

Top 5 holdings

Ranked by weight of gross asset value at month end.

#CodeSecurityWeight
1CSLCSL Ltd3.1%
2PMEPRO MEDICUS LTD3.0%
3FUELBetashares Global Energy Comp Currency Hedged ETF3.0%
4SNASGlobal X Ultra Short Nasdaq 100 Complex ETF3.0%
5ANZANZ GROUP HOLDINGS LTD2.9%

Large / mid / small cap exposure

Direct Australian stock sleeve by S&P/ASX index tier. Excludes ETFs, LICs and cash.

Direct stocks = 25.5% of portfolio. Bars below show the composition of that sleeve.

  • Large (ASX 50)
    83.7%
  • Mid (ASX 51-100)
    16.3%

Portfolio breakdown

Sector uses GICS for direct stocks. All ETFs are aggregated as 'Thematic ETFs'.

Asset class

3 groups

Sector / theme

9 groups
Important information

Performance figures shown are for the Avangard Australian equity strategy and combine the closed Avangard Alpha Fund (23 January 2025 to its final pricing date, 25 June 2026) with the current Avangard Systematic Australian Equity Fund from 6 July 2026. The benchmark shown is the S&P/ASX 200 Accumulation Index. Alpha is calculated as strategy return minus benchmark return over the same period. Strategy returns are calculated from unit prices and are net of all fees, including management and performance fees.

Past performance is not a reliable indicator of future performance. Returns are historical, are not guaranteed and may vary. Portfolio holdings, sector and market-cap allocations shown are point-in-time at month end and will change without notice.

This report is issued by Avangard Investments Pty Ltd (ACN 698 681 248), a corporate authorised representative (CAR No. 001321538) of FB Corp Limited (ABN 16 675 876 490, AFSL 557810), and is available to wholesale clients only under s761G of the Corporations Act 2001 (Cth). It is general information and does not take account of the objectives, financial situation or needs of any particular person. You should consider the appropriateness of the information having regard to your own circumstances before making any investment decision.